TigerTox: Drug Abuse Liability Tests: Slides and Commentary | TigerTox http://bit.ly/DrugAbuseLiabilityScreening #pharma #toxicology #preclinical #in
The U.S. Food and Drug Administration today approved Rituxan (rituximab), in combination with glucocorticoids (steroids), to treat patients with Wegener’s granulomatosis (WG) and microscopic polyangiitis (MPA), two rare disorders that cause blood vessel inflammation...
The U.S. Food and Drug Administration today approved Rituxan (rituximab), in combination with glucocorticoids (steroids), to treat patients with Wegener’s granulomatosis (WG) and microscopic polyangiitis (MPA), two rare disorders that cause blood vessel inflammation...
TigerTox: Personalized Medicine, A Long Way to the Bedside http://bit.ly/PersonalizedMedStatus #pharma #in #drug
TigerTox: Drug Abuse Liability Testing | TigerTox http://bit.ly/DrugAbuseLiabilityScreening
